세계의 고순도 탁시폴린 시장 : 시장 점유율과 순위, 전체 매출 및 수요 예측(2025-2031년)

The global High Purity Taxifolin market size was valued at US$ 26.74 million in 2024 and is forecast to reach US$ 35.66 million by 2031 with a CAGR of 4.06% during the forecast period 2025-2031.

The global key companies of High Purity Taxifolin include Ametis JSC, Jilin Jianwei Natural Biotechnology, Kalenika Group, ROBIOS, Xi'an Sost Biotech Co.,Ltd, Focusherb, Hoycome, etc. In 2024, the global five largest players hold a share approximately 91% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for High Purity Taxifolin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of High Purity Taxifolin by region & country, by Type, and by Application.

The High Purity Taxifolin market size, estimations, and forecasts are provided in terms of sales volume (kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding High Purity Taxifolin.

Market Segmentation

By Company

• Ametis JSC
• Jilin Jianwei Natural Biotechnology
• Kalenika Group
• ROBIOS
• Xi'an Sost Biotech Co.,Ltd
• Focusherb
• Hoycome
• Herbchem Biotech

Segment by Type

• 92%- 98%
• Above 98%

Segment by Application

• Healthcare
• Food and Beverage
• Cosmetics
• Others

By Region

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Rest of Europe
• South America
• Brazil
• Rest of South America
• Middle East & Africa
• Middle East
• Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of High Purity Taxifolin manufacturer's competitive landscape, price, sales and revenue market share, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of High Purity Taxifolin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of High Purity Taxifolin in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 High Purity Taxifolin Product Introduction
• 1.2 Global High Purity Taxifolin Market Size Forecast
  • 1.2.1 Global High Purity Taxifolin Sales Value (2020-2031)
  • 1.2.2 Global High Purity Taxifolin Sales Volume (2020-2031)
  • 1.2.3 Global High Purity Taxifolin Sales Price (2020-2031)
• 1.3 High Purity Taxifolin Market Trends & Drivers
  • 1.3.1 High Purity Taxifolin Industry Trends
  • 1.3.2 High Purity Taxifolin Market Drivers & Opportunity
  • 1.3.3 High Purity Taxifolin Market Challenges
  • 1.3.4 High Purity Taxifolin Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global High Purity Taxifolin Players Revenue Ranking (2024)
• 2.2 Global High Purity Taxifolin Revenue by Company (2020-2025)
• 2.3 Global High Purity Taxifolin Players Sales Volume Ranking (2024)
• 2.4 Global High Purity Taxifolin Sales Volume by Company Players (2020-2025)
• 2.5 Global High Purity Taxifolin Average Price by Company (2020-2025)
• 2.6 Key Manufacturers High Purity Taxifolin Manufacturing Base and Headquarters
• 2.7 Key Manufacturers High Purity Taxifolin Product Offered
• 2.8 Key High Purity Taxifolin Manufacturers, Established Time
• 2.9 High Purity Taxifolin Market Competitive Analysis
  • 2.9.1 High Purity Taxifolin Market Concentration Rate (2020-2025)
  • 2.9.2 Global 3 and 5 Largest Manufacturers by High Purity Taxifolin Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in High Purity Taxifolin as of 2024)

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 92%- 98%
  • 3.1.2 Above 98%
• 3.2 Global High Purity Taxifolin Sales Value by Type
  • 3.2.1 Global High Purity Taxifolin Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global High Purity Taxifolin Sales Value, by Type (2020-2031)
  • 3.2.3 Global High Purity Taxifolin Sales Value, by Type (%) (2020-2031)
• 3.3 Global High Purity Taxifolin Sales Volume by Type
  • 3.3.1 Global High Purity Taxifolin Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global High Purity Taxifolin Sales Volume, by Type (2020-2031)
  • 3.3.3 Global High Purity Taxifolin Sales Volume, by Type (%) (2020-2031)
• 3.4 Global High Purity Taxifolin Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Healthcare
  • 4.1.2 Food and Beverage
  • 4.1.3 Cosmetics
  • 4.1.4 Others
• 4.2 Global High Purity Taxifolin Sales Value by Application
  • 4.2.1 Global High Purity Taxifolin Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global High Purity Taxifolin Sales Value, by Application (2020-2031)
  • 4.2.3 Global High Purity Taxifolin Sales Value, by Application (%) (2020-2031)
• 4.3 Global High Purity Taxifolin Sales Volume by Application
  • 4.3.1 Global High Purity Taxifolin Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global High Purity Taxifolin Sales Volume, by Application (2020-2031)
  • 4.3.3 Global High Purity Taxifolin Sales Volume, by Application (%) (2020-2031)
• 4.4 Global High Purity Taxifolin Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global High Purity Taxifolin Sales Value by Region
  • 5.1.1 Global High Purity Taxifolin Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global High Purity Taxifolin Sales Value by Region (2020-2025)
  • 5.1.3 Global High Purity Taxifolin Sales Value by Region (2026-2031)
  • 5.1.4 Global High Purity Taxifolin Sales Value by Region (%), (2020-2031)
• 5.2 Global High Purity Taxifolin Sales Volume by Region
  • 5.2.1 Global High Purity Taxifolin Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global High Purity Taxifolin Sales Volume by Region (2020-2025)
  • 5.2.3 Global High Purity Taxifolin Sales Volume by Region (2026-2031)
  • 5.2.4 Global High Purity Taxifolin Sales Volume by Region (%), (2020-2031)
• 5.3 Global High Purity Taxifolin Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America High Purity Taxifolin Sales Value, 2020-2031
  • 5.4.2 North America High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe High Purity Taxifolin Sales Value, 2020-2031
  • 5.5.2 Europe High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific High Purity Taxifolin Sales Value, 2020-2031
  • 5.6.2 Asia Pacific High Purity Taxifolin Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America High Purity Taxifolin Sales Value, 2020-2031
  • 5.7.2 South America High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa High Purity Taxifolin Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa High Purity Taxifolin Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions High Purity Taxifolin Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 United States
  • 6.2.1 United States High Purity Taxifolin Sales Value, 2020-2031
  • 6.2.2 United States High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031
  • 6.2.3 United States High Purity Taxifolin Sales Value by Application, 2024 VS 2031
• 6.3 Europe
  • 6.3.1 Europe High Purity Taxifolin Sales Value, 2020-2031
  • 6.3.2 Europe High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 Europe High Purity Taxifolin Sales Value by Application, 2024 VS 2031
• 6.4 China
  • 6.4.1 China High Purity Taxifolin Sales Value, 2020-2031
  • 6.4.2 China High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 China High Purity Taxifolin Sales Value by Application, 2024 VS 2031
• 6.5 Japan
  • 6.5.1 Japan High Purity Taxifolin Sales Value, 2020-2031
  • 6.5.2 Japan High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 Japan High Purity Taxifolin Sales Value by Application, 2024 VS 2031
• 6.6 South Korea
  • 6.6.1 South Korea High Purity Taxifolin Sales Value, 2020-2031
  • 6.6.2 South Korea High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 South Korea High Purity Taxifolin Sales Value by Application, 2024 VS 2031
• 6.7 Southeast Asia
  • 6.7.1 Southeast Asia High Purity Taxifolin Sales Value, 2020-2031
  • 6.7.2 Southeast Asia High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 Southeast Asia High Purity Taxifolin Sales Value by Application, 2024 VS 2031
• 6.8 India
  • 6.8.1 India High Purity Taxifolin Sales Value, 2020-2031
  • 6.8.2 India High Purity Taxifolin Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 India High Purity Taxifolin Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Ametis JSC
  • 7.1.1 Ametis JSC Company Information
  • 7.1.2 Ametis JSC Introduction and Business Overview
  • 7.1.3 Ametis JSC High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Ametis JSC High Purity Taxifolin Product Offerings
• 7.2 Jilin Jianwei Natural Biotechnology
  • 7.2.1 Jilin Jianwei Natural Biotechnology Company Information
  • 7.2.2 Jilin Jianwei Natural Biotechnology Introduction and Business Overview
  • 7.2.3 Jilin Jianwei Natural Biotechnology High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Jilin Jianwei Natural Biotechnology High Purity Taxifolin Product Offerings
• 7.3 Kalenika Group
  • 7.3.1 Kalenika Group Company Information
  • 7.3.2 Kalenika Group Introduction and Business Overview
  • 7.3.3 Kalenika Group High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Kalenika Group High Purity Taxifolin Product Offerings
• 7.4 ROBIOS
  • 7.4.1 ROBIOS Company Information
  • 7.4.2 ROBIOS Introduction and Business Overview
  • 7.4.3 ROBIOS High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 ROBIOS High Purity Taxifolin Product Offerings
• 7.5 Xi'an Sost Biotech Co.,Ltd
  • 7.5.1 Xi'an Sost Biotech Co.,Ltd Company Information
  • 7.5.2 Xi'an Sost Biotech Co.,Ltd Introduction and Business Overview
  • 7.5.3 Xi'an Sost Biotech Co.,Ltd High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Xi'an Sost Biotech Co.,Ltd High Purity Taxifolin Product Offerings
• 7.6 Focusherb
  • 7.6.1 Focusherb Company Information
  • 7.6.2 Focusherb Introduction and Business Overview
  • 7.6.3 Focusherb High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Focusherb High Purity Taxifolin Product Offerings
  • 7.6.5 Focusherb Recent Development
• 7.7 Hoycome
  • 7.7.1 Hoycome Company Information
  • 7.7.2 Hoycome Introduction and Business Overview
  • 7.7.3 Hoycome High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Hoycome High Purity Taxifolin Product Offerings
• 7.8 Herbchem Biotech
  • 7.8.1 Herbchem Biotech Company Information
  • 7.8.2 Herbchem Biotech Introduction and Business Overview
  • 7.8.3 Herbchem Biotech High Purity Taxifolin Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Herbchem Biotech High Purity Taxifolin Product Offerings

8 Industry Chain Analysis

• 8.1 High Purity Taxifolin Industrial Chain
• 8.2 High Purity Taxifolin Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Process
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 High Purity Taxifolin Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 High Purity Taxifolin Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
  • 10.1.2 Data Source
• 10.2 Author Details
• 10.3 Disclaimer